...
首页> 外文期刊>The international journal of artificial organs >Validation of a two-pool model for the kinetics of beta2-microglobulin.
【24h】

Validation of a two-pool model for the kinetics of beta2-microglobulin.

机译:β2-微球蛋白动力学两池模型的验证。

获取原文
获取原文并翻译 | 示例
           

摘要

Secondary amyloidosis due to beta-2-microglobulin (beta2-m) is a serious long-term complication in patients on regular dialysis therapy. Beta2-m can be considered a middle-molecule marker used to facilitate the assessment of dialysis efficacy. For this purpose, a validated model that calculates characteristic efficacy parameters, such as Kt/V, TAC and generation rate, is needed. There is general agreement that beta2-m-kinetics should be described by a two-pool model, but little has been published to validate such an approach. We measured the beta2-m concentration profiles of eight stable patients during hemodialysis (HD) at the start of treatment, after 30 minutes, after 60 minutes, and every hour until the end. Thereafter they were measured at 10-minute intervals for an hour. The dialyser clearances were determined from the plasma concentrations in front of and behind the dialyser twice during each session - after 1 hour, and 4 hours from the start of treatment. The kinetic parameters of a two-pool model (e.g. the compartment volumes V1 and V2, the mass transfer coefficient K12 and the generation rate G) were determined from the optimal fit of the measured concentration profile. The table below summarises the results by giving the mean and standard deviation for each parameter: [table: see text]. Inter-individual differences in V1/V2 and K12 were high, ranging from 2.5 to 10.0 for V/V2 and from 26 to 140 for K12. Error analysis suggested that these wide ranges were due to the method and that in reality the probable range of V is 25-36% of TBW, of V1/V2 3.5-5.3, and of K12 30-80 ml/min. With standard values for these three parameters (V = 30% of TBW, V/V2 = 4.4 and K12 = 55 ml/m), equal for all patients, and their respective ranges, Kt/W can be calculated with a standard deviation of 13%. Kt/W > 1.2 secures the maximum possible beta2-m removal with three HD treatments a week. CONCLUSIONS: The parameters of a two-pool model of beta2-m kinetics can be derived from concentration profiles obtained under routine dialysis conditions, but accuracy is not completely satisfactory. Similar to the dialysis dose for urea (Kt/Vurea) the dialysis dose for beta2-m (Kt/Vbeta2-m) can be calculated from the pre- and post-dialysis concentrations of beta2-m, body weight, ultrafiltration and dialysis time. Kt/Vbeta2-m > 1.2 secures the maximum possible removal of beta2-m in HD with three sessions per week.
机译:在接受常规透析治疗的患者中,由于β-2-微球蛋白(β2-m)引起的继发性淀粉样变性是严重的长期并发症。 Beta2-m可以被认为是一种中分子标记,可用于评估透析功效。为此,需要一个经过验证的模型来计算特征功效参数,例如Kt / V,TAC和发电率。人们普遍同意应通过两池模型来描述beta2-m动力学,但很少有文献证实这种方法。在治疗开始,30分钟之后,60分钟之后以及每小时直至结束的过程中,我们在血液透析(HD)期间测量了8位稳定患者的beta2-m浓度分布。此后,以10分钟的间隔测量它们一个小时。在每个疗程中两次透析器前后的血浆浓度确定透析器清除率-从治疗开始后1小时和4小时。根据测量的浓度曲线的最佳拟合确定两池模型的动力学参数(例如,隔室容积V1和V2,传质系数K12和生成速率G)。下表通过给出每个参数的平均值和标准偏差来总结结果:[表:请参见文本]。 V1 / V2和K12之间的个体差异很高,V / V2在2.5到10.0之间,K12在26到140之间。误差分析表明,这些宽范围是由于该方法引起的,实际上,V的可能范围是TBW的25-36%,V1 / V2的3.5-5.3和K12 30-80 ml / min。在这三个参数的标准值(V = TBW的30%,V / V2 = 4.4和K12 = 55 ml / m)下,对于所有患者及其各自的范围均相等,可以用标准差为的方式计算Kt / W 13%。 Kt / W> 1.2可确保每周通过三种HD治疗最大限度地去除beta2-m。结论:可以从常规透析条件下获得的浓度分布图得出β2-m动力学双池模型的参数,但准确性并不完全令人满意。类似于尿素的透析剂量(Kt / Vurea),β2-m的透析剂量(Kt / Vbeta2-m)可以通过透析前后的β2-m浓度,体重,超滤和透析时间来计算。 Kt / Vbeta2-m> 1.2可以确保每周通过三个会话最大程度地清除HD中的beta2-m。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号